Veterinary Healthcare Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 58.30 Billion |
| Market Size (2029) | USD 85.14 Billion |
| CAGR (2024 - 2029) | 6.83 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Veterinary Healthcare Market Analysis
The Veterinary Healthcare Market size is estimated at USD 58.30 billion in 2024, and is expected to reach USD 85.14 billion by 2029, growing at a CAGR of 6.83% during the forecast period (2024-2029).
Supply disruptions and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for therapy for the treatment of COVID-19. Governments are taking measures to mitigate the supply of medicines. For instance, in 2020, the European Medicines Agency issued guidance for companies responsible for veterinary medicines concerning adaptations to the regulatory framework, primarily to address the challenges faced during this pandemic. Also, the Centers for Disease Control and Prevention, in July 2020, recommended specific guidelines to veterinary professionals for treating companion animals during the COVID-19 pandemic. Hence, it is observed that the pandemic had a significant impact on the market studied. However, the market has reached pre-pandemic in terms of demand for veterinary health products and services. The market is expected to witness significant growth in a short period.
The market is primarily driven by the approval of new products related to treating animal disorders. For instance, in June 2022, DechraVeterinary Products announced that it is VETRADENT Liquid Water Additive for dogs and cats and received the seal of acceptance to help control tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after adequately demonstrating safety and efficacy. Also, in October 2021, BASF Animal Nutrition, a supplier of innovative feed additives for livestock, aquaculture, and companion animals, and trinamiXGmbH, a wholly owned subsidiary of BASF SE, joined forces to introduce trinamiX' Mobile Near Infrared (NIR) Spectroscopy Solution to the feed industry. With this launch, the portable NIR solution provides customers across the entire value chain with a fast and reliable on-site analysis of animal feed and ingredients. With the launch of such veterinary products, the market studied is expected to witness healthy growth in the coming years.
Many companies focus on frequent product launches that may drive worldwide growth. For instance, in June 2022, R-BiopharmAG acquired AusDiagnostics. With the acquisition, R-Biopharmexpanded its product portfolio with molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment for animals and humans. In addition, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to meet better the challenges of diagnosing and treating cancer. The expansion includes a liquid biopsy test that utilizes next-generation DNA sequencing technology to diagnose canine cancers. Hence, the market for veterinary healthcare is expected to witness substantial growth over the forecast period due to the aforementioned factors.
However, the high cost of diagnostic imaging equipment and veterinary medicines and the high price of veterinary services is anticipated to restrain the market's growth over the forecast period.
Veterinary Healthcare Market Trends
This section covers the major market trends shaping the Veterinary Healthcare Market according to our research experts:
Vaccine Segment Expected to Hold the Significant Share Over the Forecast Period
Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. New advanced vaccines have been manufactured containing genetically engineered components derived from those disease agents. Companies like Merck Animal Health hosted a virtual event in March 2022 featuring public health, veterinary medicine, and parasitology experts, who will share their perspectives on managing the threat of vector-borne diseases (VBDs). The One Health approach is uniquely suited to help prevent the emergence and spread of VBDs through traceability, appropriate vaccination policies, and ongoing monitoring and treatment.
Additionally, market players are developing and launching new vaccines globally to enhance their market presence. For instance, in March 2021, the world's first animal vaccine against the novel coronavirus was registered in Russia, named Carnivac-Cov, developed by a unit of Rosselkhoznadzor(Federal Service for Veterinary and Phytosanitary Surveillance. The clinical trials of Carnivac-Cov were started in October 2021 and involved dogs, cats, and other animals.
In July 2021, Zoetis donated more than 11,000 doses of its experimental COVID-19 vaccine to help protect the health and well-being of more than 100 mammalian species living in nearly 70 zoos, as well as more than a dozen conservatories, sanctuaries, academic institutions, and government organizations located in 27 states.
Additionally, in June 2022, in India, the Union Minister of Agriculture & farmers, farmers Shri Narendra Singh Tomar, launched animal vaccines and other diagnostic kits developed by the ICAR-National Research Centre on Equines. The AncovaxVaccine on Equines is an inactivated SARS-CoV-2 Delta (COVID-19) Vaccine for Animals. The immunity induced by Ancovaxneutralizes both Delta and Omicron Variants of SARS-CoV-2. The vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogelas as an adjuvant. Therefore, owing to such new launches in veterinary vaccines, the segment is believed to witness substantial growth across the globe in the coming years.
North America Expected to Hold the Largest Market Share over the Forecast Period
North America is one of the most developed regions in the world. It currently holds the major share of the veterinary healthcare market, and it is expected to follow the same trend over the forecast period. With the increasing initiatives by various organizations in North American countries coupled with the high adoption of pets, the market studied is expected to show strong growth.
For instance, in September 2022, Best Friends Animal Society, an animal welfare organization working to end the killing of cats and dogs in America's shelters by 2025, announced that it is teaming up with more than 600 shelter and rescue partners across the United States for its third nationwide adoption campaign in six months to encourage people to choose to adopt, not buy, their next pet. Thus, increasing pet adoption in the United States. Best Friends Animal Society is a pioneer in the no-kill movement and has helped reduce the number of animals killed in shelters from an estimated 17 million per year to around 355,000. Best Friend's Animal Society also reported that in 2021, around 355,000 dogs and cats were killed in shelters in the United States as these animals were not owned. With such initiatives, the veterinary healthcare market is growing significantly.
Similarly, in August 2022, California Animal Welfare Funders Collaborative (CAWFC) awarded USD 300,000 in grants to 19 organizations to make the largest possible impact on people and their pets across the state, to provide the pets with proper food, medicines, and diagnostics as required. Such high funding for animal welfare indicates the rising focus on veterinary health which is contributing largely to the market growth.
In addition, the data published by 'Pet Keen' in May 2022 shows that nearly 38% of Canadian households owned a cat, while 35% owned a dog in 2021. Also, the source mentioned above estimated that pet owners in Canada are spending more money on their pets than before, and 17% of owners are willing to spend more than USD 500 every year for their pet healthcare. This awareness about pet healthcare among pet owners is expected to create demand for products and services available for per-animal healthcare. Thereby driving the studied market growth.
Veterinary Healthcare Industry Overview
Major companies have undertaken several business strategies to gain a competitive edge, such as regional expansion, mergers and acquisitions, and collaborative research initiatives. Some of the key players in the market studied are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Vetoquinol SA, Zoetis Inc., and IDEXX Laboratories, among others.
Veterinary Healthcare Market Leaders
-
Zoetis Inc.
-
Boehringer Ingelheim International GmbH
-
Elanco Animal Health
-
Ceva
-
Vetoquinol
*Disclaimer: Major Players sorted in no particular order
Veterinary Healthcare Market News
- In September 2022, Merck Animal Health announced the new label indication for both Bravectoand BravectoPlus for topical use in cats to treat and control Asian long-horned tick infestations. Bravectoand BravectoPlus for cats is the first and only U.S. product labeled for treatment and control. The Asian long-horned tick is an invasive Ixodid tick native to Japan, China, eastern Russia, & Korea.
- In January 2022, Zoetis announced that the U.S. Food and Drug Administration (FDA) had approved a new label indication for SimparicaTrio (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks). SimparicaTrio is approved for dogs eight weeks of age and older.
Veterinary Healthcare Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Advanced Technologies Leading to Innovations in Animal Healthcare
- 4.2.2 Increasing Initiatives by Governments and Animal Welfare Associations Globally
- 4.2.3 Increasing Productivity at the Risk of Emerging Zoonosis
-
4.3 Market Restraints
- 4.3.1 Use of Counterfeit Medicines
- 4.3.2 Increasing Cost of Animal Testing and Veterinary Services
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Therapeutics
- 5.1.1.1 Vaccines
- 5.1.1.2 Parasiticides
- 5.1.1.3 Anti-infectives
- 5.1.1.4 Medical Feed Additives
- 5.1.1.5 Other Therapeutics
- 5.1.2 Diagnostics
- 5.1.2.1 Immunodiagnostic Tests
- 5.1.2.2 Molecular Diagnostics
- 5.1.2.3 Diagnostic Imaging
- 5.1.2.4 Clinical Chemistry
- 5.1.2.5 Other Diagnostics
-
5.2 By Animal Type
- 5.2.1 Dogs and Cats
- 5.2.2 Horses
- 5.2.3 Ruminants
- 5.2.4 Swine
- 5.2.5 Poultry
- 5.2.6 Other Animal Types
-
5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 France
- 5.3.2.2 Germany
- 5.3.2.3 United Kingdom
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East & Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Norbrook
- 6.1.2 Boehringer Ingelheim International GmbH
- 6.1.3 Ceva Animal Health LLC
- 6.1.4 Elanco Animal Health
- 6.1.5 Idexx Laboratories
- 6.1.6 Innovative Diagnostics (IDVet)
- 6.1.7 INDICAL Bioscience GmbH
- 6.1.8 Merck & Co. Inc.
- 6.1.9 Phibro Animal Health
- 6.1.10 Randox Laboratories Ltd
- 6.1.11 Thermo Fisher Scientific
- 6.1.12 Vetoquinol
- 6.1.13 Virbac SA
- 6.1.14 Zoetis Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Healthcare Industry Segmentation
Veterinary healthcare can be defined as the science associated with diagnosing, treating, and preventing animal diseases. The increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. The Veterinary Healthcare Market is Segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animal Types), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | Therapeutics | Vaccines |
| Parasiticides | ||
| Anti-infectives | ||
| Medical Feed Additives | ||
| Other Therapeutics | ||
| By Product | Diagnostics | Immunodiagnostic Tests |
| Molecular Diagnostics | ||
| Diagnostic Imaging | ||
| Clinical Chemistry | ||
| Other Diagnostics | ||
| By Animal Type | Dogs and Cats | |
| Horses | ||
| Ruminants | ||
| Swine | ||
| Poultry | ||
| Other Animal Types | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | France |
| Germany | ||
| United Kingdom | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East & Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Veterinary Healthcare Market Research FAQs
How big is the Veterinary Healthcare Market?
The Veterinary Healthcare Market size is expected to reach USD 58.30 billion in 2024 and grow at a CAGR of 6.83% to reach USD 85.14 billion by 2029.
What is the current Veterinary Healthcare Market size?
In 2024, the Veterinary Healthcare Market size is expected to reach USD 58.30 billion.
Who are the key players in Veterinary Healthcare Market?
Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva and Vetoquinol are the major companies operating in the Veterinary Healthcare Market.
Which is the fastest growing region in Veterinary Healthcare Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Veterinary Healthcare Market?
In 2024, the North America accounts for the largest market share in Veterinary Healthcare Market.
What years does this Veterinary Healthcare Market cover, and what was the market size in 2023?
In 2023, the Veterinary Healthcare Market size was estimated at USD 54.57 billion. The report covers the Veterinary Healthcare Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Veterinary Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Veterinary Healthcare Industry Report
Statistics for the 2024 Veterinary Healthcare market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Healthcare analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
